List of bibliographic references
Number of relevant bibliographic references: 11.
| Ident. | Authors (with country if any) | Title |
|---|
| 000291 (2012) |
Christel Renoux [Canada] ; Sophie Dell'Aniello [Canada] ; James M. Brophy [Canada] ; Samy Suissa [Canada] | Dopamine agonist use and the risk of heart failure |
| 000627 (2010) |
Juliana Bronzova [Pays-Bas] ; Cristina Sampaio [Portugal] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Ad Theeuwes [Pays-Bas] ; Serge V. Van De Witte [Pays-Bas] ; Guus Van Scharrenburg [Pays-Bas] | Double‐blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease |
| 000779 (2009) |
Philip Seeman [Canada] ; Hong-Chang Guan [Canada] | Glutamate agonist LY404,039 for treating schizophrenia has affinity for the dopamine D2High receptor |
| 000908 (2008) |
Philip Seeman [Canada] ; Carla Caruso [Argentine] ; Mercedes Lasaga [Argentine] | Memantine agonist action at dopamine D2High receptors |
| 000A56 (2007) |
Philip Seeman [Canada] ; Patrick N. Mccormick [Canada] ; Shitij Kapur [Canada] | Increased dopamine D2High receptors in amphetamine‐sensitized rats, measured by the agonist [3H](+)PHNO |
| 000B42 (2006) |
Maryvonne Le Saux [Canada] ; Erika Estrada-Camarena [Canada] ; Thérèse Di Paolo [Canada] | Selective estrogen receptor‐α but not ‐β agonist treatment modulates brain α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid receptors |
| 000F86 (2001) |
J. Thomas Hutton [États-Unis] ; Leo Verhagen Metman [États-Unis] ; Thomas N. Chase [États-Unis] ; Jorge L. Juncos [États-Unis] ; William C. Koller [États-Unis] ; Rajesh Pahwa [États-Unis] ; Peter A. Lewitt [États-Unis] ; Ali Samii [Canada] ; Joseph K. C. Tsui [Canada] ; Donald B. Calne [Canada] ; Cheryl H. Waters [États-Unis] ; Vincent P. Calabrese [États-Unis] ; James P. Bennett [États-Unis] ; Richard Barrett [États-Unis] ; Jerry L. Morris [États-Unis] | Transdermal dopaminergic D2 receptor agonist therapy in Parkinson's disease with N‐0923 TDS: A double‐blind, placebo‐controlled study |
| 001866 (1996) |
P. J. Blanchet [Canada] ; R. Grondin [Canada] ; R. Bédard [Canada] | Dyskinesia and wearing‐off following dopamine D1 agonist treatment in drug‐naive 1‐Methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐lesioned primates |
| 001879 (1996) |
R. Grondin [Canada] ; M. Goulet [Canada] ; T. Di Paolo [Canada] ; P. J. Bédard [Canada] | Cabergoline, a long-acting dopamine D2-like receptor agonist, produces a sustained antiparkinsonian effect with transient dyskinesias in parkinsonian drug-naive primates |
| 001A01 (1995) |
F. Calon [Canada] ; M. Goulet [Canada] ; P. J. Blanchet [Canada] ; J. C. Martel [Canada] ; M. F. Piercey [États-Unis] ; P. J. Be Dard [Canada] ; T. Di Paolo [Canada] | Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA, receptors in the striatopallidal complex |
| 002460 (1986) |
S. H. Brown [Canada] ; J. D. Cooke [Canada] | Initial agonist burst is modified by perturbations preceding movement |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Istex/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i -k "agonist"
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i \
-Sk "agonist" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Istex
|étape= Checkpoint
|type= indexItem
|index= Title.i
|clé= agonist
}}
| This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022 |  |
